Polioviral receptor binding ligand: A novel and safe peptide drug carrier from polioviral capsid

Drug Delivery

Volumn 19, Issue 1, 2012, Pages 21-27

  Manosroi, Jiradej ^a   Lohcharoenkal, Warangkana ^a   Götz, Friedrich ^b   Werner, Rolf G ^c   Manosroi, Worapaka ^d   Manosroi, Aranya ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

cellular uptake; GFP; Poliovirus; tat; VP1 capsid protein

Indexed keywords

DRUG CARRIER; GREEN FLUORESCENT PROTEIN; POLIOVIRAL PROTEIN VP1; PROTEIN VP1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HT29; CELL STRAIN KB; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OSMOLARITY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; CAPSID PROTEINS; CELL SURVIVAL; DRUG CARRIERS; GREEN FLUORESCENT PROTEINS; HT29 CELLS; HUMANS; KB CELLS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, VIRUS;

EID: 84855400959     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2011.621991     Document Type: Article

References (36)

1. Beuria, T.K., Shah, J.H., Santra, M.K., Kumar, V. , Panda, D. (2006). Efects of pH and ionic strength on the assembly and bundling of FtsZ protoflaments: A possible role of electrostatic interactions in the bundling of protoflaments. Int J Biol Macromol. 40:30-9. (Pubitemid 44809405)
2. Bradford, M.A. (1976). A rapid and sensitive method for the quantifcation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248-54.
3. Brooks, H., Lebleu, B., Vivès, E. (2005). Tat peptide-mediated cellular delivery: Back to basics. Adv Drug Deliv Rev. 57:559-77. (Pubitemid 40255561)
4. Chen, C.P., Chou, J.C., Liu, B.R., Chang, M., Lee, H.J. (2007). Transfection and expression of plasmid DNA in plant cells by an arginine-rich intracellular delivery peptide without protoplast preparation. FEBS Lett. 581:1891-7. (Pubitemid 46602278)
5. Chung, T.H., Wu, S.H., Yao, M., Lu, C.W., Lin, Y.S., Hung, Y., Mou, C.Y., Chen, Y.C., Huang, D.M. (2007). The efect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials. 28:2959-66. (Pubitemid 46560868)
6. El-Andaloussi, S., Järver, P., Johansson, H.J., Langel, Ü., (2007). Cargo-dependent cytotoxicity and delivery efcacy of cell-penetrating peptides: a comparative study. Biochem J. 407:285-92. (Pubitemid 47556993)
7. Furuhata, M., Kawakami, H., Toma, K., Hattori, Y., Maitani, Y. (2006). Intracellular delivery of proteins in complexes with oligoarginine-modifed liposomes and the efect of oligoarginine length. Bioconjugate Chem. 17:935-42. (Pubitemid 44162611)
8. Golovanov, A.P., Hautbergue, G.M., Wilson, S.A., Lian, L.Y. (2004). A simple method for improving protein solubility and long-term stability. J Am Chem Soc. 126:8933-9. (Pubitemid 38971066)
9. Gorajana, A., Rajendran, A., Rao, N.K. (2010). Preparation and in vitro evaluation of solid dispersions of nimodipine using PEG 4000 and PVPK30. JPRHC. 2:163-9.
10. Grant, R.A., Hiremath, C.N., Filman, D.J., Syed, R., Andries, K., Hogle, J.M. (1994). Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr Biol. 4:784-97. (Pubitemid 124001574)
11. Green, M., Loewenstein, P.M. (1998). Autonomous functional domains of chemically synthesized human immunodefciency virus tat trans-activator protein. Cell. 55:1179-88.
12. Gump, J.M., Dowdy, S.F. (2007). Tat transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med. 13:443-8. (Pubitemid 47562310)
13. Hamman, J.H., Enslin, G.M., Kotzé, A.F. (2005). Oral delivery of peptide drugs: Barriers and developments. BioDrugs. 19:165-77. (Pubitemid 40994232)
14. He, Y., Bowman, V.D., Mueller, S., Bator, C.M., Bella, J., Peng, X., Baker, T.S., Wimmer, E., Kuhn, R.J., Rossman, M.G. (2000). Interaction of the poliovirus receptor with poliovirus. PNAS. 97:79-84. (Pubitemid 30055787)
15. Hu, J.W., Liu, B.R., Wu, C.Y., Lu, S.W., Lee, H.J. (2009). Protein transport in human cells mediated by covalently and noncovalently conjugated arginine-rich intracellular delivery peptides. Peptides. 30:1669-78.
16. Kamei, N., Morishita, M., Eda, Y., Ida, N., Nishio, R., Takayama, K. (2008). Usefulness of cell-penetrating peptides to improve intestinal insulin absorption. J Contr Rel. 132:21-5.
17. Khafagy, E.S., Morishita, M., Kamei, N., Eda, Y., Ikeno, Y., Takayama, K. (2009). Efciency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins. Int J Pharms. 381:49-55.
18. Kilk, K., Mahlapuu, R., Soomets, U., Langel, U. (2009). Analysis of in vitro toxicity of fve cell-penetrating peptides by metabolic profling. Toxicology. 265:87-95.
19. Lee, H.E., Lee, M.J., Park, C.R., Kim, A.Y., Chun, K.H., Hwang, H.J., Oh, D.H., Jeon, S.O., Kang, J.S., Jung, T.S., Choi, G.J., Lee, S. (2010). Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery. J Contr Rel. 143:251-7.
20. Li, Y., Dubin, P.L., Havel, H.A., Edwards, S.L., Dautzenberg, H. (1995). Electrophoretic light scattering, dynamic light scattering, and turbidimetry studies of the efect of polymer concentration on complex formation between polyelectrolyte and oppositely charged mixed micelles. Macromolecules. 28:3098-102.
21. Liang, J.F., Yang, V.C. (2005). Insulin-cell penetrating peptide hybrids with improved intestinal absorption efciency. Biochem Biophys Res Commun. 335:734-8. (Pubitemid 41188260)
22. Manosroi, J., Lohcharoenkal, W., Götz, F., Werner, R.G., Manosroi, W., Manosroi, A. (2011). Transdermal absorption enhancement of N-terminal Tat-GFP fusion protein (TG) loaded in novel low toxic elastic anionic niosomes. J Pharm Sci. 100:1525-34.
23. Pelletier, I., Ouzilou, L., Arita, M., Nomoto, A., Colbère- Garapin, F. (2003). Characterization of the Poliovirus 147S particle: New insights into Poliovirus uncoating. Virology. 305:55-65. (Pubitemid 36062812)
24. Pichayakorn, W., Kusonwiriyawong, C., Ritthidej, G.C. (2003). Oral peptide and protein drug delivery. Tai J Pharm Sci. 27:91-108.
25. Rieux, A., Fievez, V., Garinot, M., Schneider, Y.J., Préat, V. (2006). Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Contr Rel. 116:1-27. (Pubitemid 44792295)
26. Sæther, H.V., Holme, H.K., Maurstad, G., Smidsrød, O., Stokke, B.T. (2008). Polyelectrolyte complex formation using alginate and chitosan. Carbohydrate Polymer. 74:813-21.
27. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S., Boyd, M.R. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 82:1107-12. (Pubitemid 20213250)
28. Strijbos, P.J.L.M., Zamani, M.R., Rothwell, N.J., Arbuthnott, G., Harkiss, G. (1995). Neurotoxic mechanisms of transactivating protein Tat of Maedi-Visna virus. Neurosci Lett. 197:215-8.
29. Takayama, K., Nakase, I., Michiue, H., Takeuchi, T., Tomisawa, K., Mutsui, H., Futaki, S. (2009). Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas). J Contr Rel. 138:128-33.
30. Trabulo, S., Cardoso, A.L., Mano, M., Pedroso de Lima, M.C. (2010). Cell penetrating peptides-Mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals. 3:961-93.
31. Tünnemann, G., Cardoso, M.C. (2008). Cell-penetrating peptides, uptake, toxicity and applications. J Pept Sci. 14:469-76.
32. Wang, Y.H., Chen, C.P., Chan, M.H., Chang, M., Hou, Y.W., Chen, H.H. (2006). Arginine-rich intracellular delivery peptides noncovalently transport protein into living cells. Biochem Biophys Res Commun. 346:758-67.
33. Watkins, C.L., Brennan, P., Fegan, C., Takayama, K., Nakase, I., Futaki, S., Jones, A.T. (2009). Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. J Contr Rel. 140:237-44.
34. Wearley, L.L. (1991). Recent progress in protein and peptide delivery by non-invasive routes. Crit Rev Ter Drug Carrier Syst. 8:331-94.
35. Yamamoto, Y., He, P., Klein, T.W., Friedman, H. (1994). Endotoxin induced cytotoxicity of macrophages is due to apoptosis caused by nitric oxide production. Innate Immunity. 1:181-7. (Pubitemid 2142048)
36. Zhang, P., Mueller, S., Morais, M.C., Bator, C.M., Bowman, V.D., Hafenstein, S., Wimmer, E., Rossmann, M.G. (2008). Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses. PNAS. 105:18284-9.